Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
Zexian ZengJingxin FuCarrie CibulskisAashna JhaveriCurtis GumbsBiswajit DasBeatriz Sanchez-EspiridionSylvie JanssensLen TaingJin WangJames R LindsayTomas VilimasJianhua ZhangCollin TokheimAvinash SahuPeng JiangChunhua YanDzifa Yawa DuoseEthan CeramiLi ChenDavid CohenQingrong ChenRebecca A EnosXin HuangJiun-Kae Jack LeeYang LiuDonna S NeubergCu NguyenCandace PattersonSharmistha SarkarSachet A ShuklaMing TangJunko TsujiMohamed UdumanXiaoman WangJason L WeiratherJijun YuJoyce YuDaoud MeerzamanMagdalena ThurinAndrew FutrealChris KarlovichStacey B GabrielIgnacio Ivan WistubaX Shirley LiuCatherine J WuPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
The CIMAC collaborating laboratory platforms effectively generated consistent WES and RNA-seq data and enable robust cross-trial comparisons and meta-analyses of highly complex immuno-oncology biomarker data across the NCI CIMAC-CIDC Network.